Desirae Twilla, PA
Physician Assistant · Murfreesboro, TNNPI 1437554318
Payments from drug & device makers
Across 190 payments — averaging $18.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$536
- Novo Nordisk$381
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$331
- AstraZeneca$245
- Boehringer Ingelheim$228
- Pfizer$151
- plus $2K from 32 others
What the payments were for
- Food & beverage$3,432100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $536 |
| Novo Nordisk | 23 | $381 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $331 |
| AstraZeneca | 15 | $245 |
| Boehringer Ingelheim | 11 | $228 |
| Pfizer | 8 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $148 |
| Johnson & Johnson | 6 | $119 |
| Otsuka America Pharmaceutical, Inc. | 5 | $116 |
| Astellas Pharma US Inc | 5 | $108 |
| Lilly USA, LLC | 6 | $90 |
| Amgen | 4 | $85 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $74 |
| Bayer | 4 | $69 |
| Boston Scientific | 3 | $54 |
| Edwards Lifesciences | 3 | $54 |
| GSK | 3 | $52 |
| Nestle Healthcare Nutrition Inc. | 3 | $45 |
| Kowa Pharmaceuticals America, Inc. | 2 | $45 |
| Nevro Corp. | 2 | $43 |
| Abbott | 2 | $42 |
| Esperion Therapeutics, Inc. | 2 | $41 |
| Vistapharm, Inc. | 3 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Nabriva Therapeutics, PLC | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Tempus AI, Inc | 1 | $26 |
| Lundbeck LLC | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Antares Pharma, Inc. | 1 | $21 |
| Vertex | 1 | $20 |
| Merck | 1 | $19 |
| Novartis | 1 | $17 |
| Exact Sciences | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Halozyme Inc | 1 | $15 |
How this compares
$3,432 in reported general payments places this provider in the 85th percentile of 2,404 physician assistant providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 54 | $72,008 |
| JardianceEmpagliflozin | 48 | $64,142 |
| RybelsusSemaglutide | 25 | $31,523 |
| FarxigaDapagliflozin Propanediol | 35 | $30,889 |
| EliquisApixaban | 36 | $25,067 |
| MounjaroTirzepatide | 15 | $23,313 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $12,318 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $11,541 |
| LinzessLinaclotide | 11 | $7,944 |
| TrintellixVortioxetine Hydrobromide | 14 | $7,361 |
| Solifenacin Succinate | 33 | $4,657 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $2,973 |
| Omeprazole | 180 | $2,849 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 145 | $2,310 |
| SynthroidLevothyroxine Sodium | 43 | $2,182 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $381 | $103,53179 claims |
| Boehringer IngelheimJardiance | $228 | $64,14248 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $245 | $42,43048 claims |
| PfizerEliquis | $151 | $25,06736 claims |
| Lilly USA, LLCMounjaro | $90 | $23,31315 claims |
| GSKTrelegy Ellipta | $52 | $12,31814 claims |
| AbbVieLinzess, Synthroid | $536 | $10,12654 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $148 | $7,36114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,404 physician assistant providers in Tennessee.
Other physician assistant in Murfreesboro
- Joseph AyersMurfreesboro$73K
- Ruchi PatelMurfreesboro$23K
- Bailey ChitwoodMurfreesboro$22K
- Taylor NewmanMurfreesboro$16K
- Kurt KnollMurfreesboro$13K
- Lindsey NixKnoxville$576K
- Anna KerseySavannah$399K
- Jason HenryNashville$329K
- Brie ChandlerNashville$317K
- Loree EasleyBartlett$209K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.